Calls Grow for Antitrust Action on Health Insurers
A growing discussion online is calling for the breakup of vertically integrated healthcare insurance giants, drawing parallels to the antitrust action against AT&T in 1984. This sentiment reflects broader frustration with the market power of consolidated payers, which directly impacts provider revenue cycles and billing pressures.
The strategy of vertical integration, where an insurer owns providers, pharmacies, and data analytics firms, has become dominant. UnitedHealth Group, with its Optum arm, is a prime example, now the largest employer of physicians in the country, with over 90,000 doctors under its umbrella. This model allows a single corporation to control every stage of the healthcare supply chain. This consolidation has not gone unnoticed by federal regulators. In March 2024, the Department of Justice, Federal Trade Commission, and Department of Health and Human Services launched a joint inquiry into the increasing corporate control over healthcare, with a specific focus on private equity's role and "serial acquisitions" of smaller providers that fly under the radar. For providers, this market power manifests in restrictive contracts. Health systems have been challenged for using anti-steering and anti-tiering clauses that prevent insurers from directing patients to more affordable competitors, thereby sustaining higher prices. This tactic limits patient choice and stifles competition among providers. Insurers and their intermediaries have also been accused of using shared pricing data and common algorithms to systematically suppress out-of-network reimbursement rates. A class-action lawsuit alleges that these practices constitute illegal price-fixing, artificially lowering what providers are paid and creating a challenging environment for independent practices to survive. The theoretical promise of vertical integration was improved efficiency and better care coordination. However, studies show that consolidation often leads to higher prices for patients without a corresponding improvement in the quality of care. One analysis calculated that if all physicians moved into integrated systems, Medicare spending could increase by over $315 million for just two common procedures. The current regulatory environment signals a potential shift. The FTC and DOJ have signaled more aggressive enforcement, scrutinizing deals that were previously unchallenged. This includes recent lawsuits to block hospital acquisitions and a focus on "corporate greed" in healthcare, indicating a renewed interest in challenging anti-competitive mergers.
